Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum

P. Barba, L. J. Burns, M. R. Litzow, M. B. Juckett, Krishna V Komanduri, S. J. Lee, S. M. Devlin, L. J. Costa, S. Khan, A. King, A. Klein, A. Krishnan, A. Malone, M. Mir, C. Moravec, G. Selby, V. Roy, M. Cochran, M. K. Stricherz, M. D. WestmorelandM. A. Perales, W. A. Wood

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The American Society for Blood and Marrow Transplantation (ASBMT) Clinical Case Forum (CCF) was launched in 2014 as an online secure tool to enhance interaction and communication among hematopoietic cell transplantation (HCT) professionals worldwide through the discussion of challenging clinical care issues. After 14 months, we reviewed clinical and demographical data of cases posted in the CCF from January 29, 2014 to March 18, 2015. A total of 137 cases were posted during the study period. Ninety-two cases (67%) were allogeneic HCT, 29 (21%) were autologous HCT, and in 16 (12%), the type of transplantation (autologous versus allogeneic) was still under consideration. The diseases most frequently discussed included non-Hodgkin lymphoma (NHL; n = 30, 22%), acute myeloid leukemia (n = 23, 17%), and multiple myeloma (MM; n = 20, 15%). When compared with the US transplantation activity reported by the US Department of Health and Human Services, NHL and acute lymphoblastic leukemia cases were over-represented in the CCF, whereas MM was under-represented (P <.001). A total of 259 topics were addressed in the CCF with a median of 2 topics/case (range, 1 to 6). Particularly common topics included whether transplantation was indicated (n = 57, 41%), conditioning regimen choice (n = 44, 32%), and post-HCT complications after day 100 (n = 43, 31%). The ASBMT CCF is a successful tool for collaborative discussion of complex cases in the HCT community worldwide and may allow identification of areas of controversy or unmet need from clinical, educational and research perspectives.

Original languageEnglish (US)
Pages (from-to)564-570
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Cell Transplantation
Transplantation
Bone Marrow
Learning
Delivery of Health Care
United States Dept. of Health and Human Services
Autologous Transplantation
Multiple Myeloma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Non-Hodgkin's Lymphoma
Communication
Research

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Autologous stem cell transplantation
  • Case discussions

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Success of an International Learning Health Care System in Hematopoietic Cell Transplantation : The American Society of Blood and Marrow Transplantation Clinical Case Forum. / Barba, P.; Burns, L. J.; Litzow, M. R.; Juckett, M. B.; Komanduri, Krishna V; Lee, S. J.; Devlin, S. M.; Costa, L. J.; Khan, S.; King, A.; Klein, A.; Krishnan, A.; Malone, A.; Mir, M.; Moravec, C.; Selby, G.; Roy, V.; Cochran, M.; Stricherz, M. K.; Westmoreland, M. D.; Perales, M. A.; Wood, W. A.

In: Biology of Blood and Marrow Transplantation, Vol. 22, No. 3, 01.03.2016, p. 564-570.

Research output: Contribution to journalArticle

Barba, P, Burns, LJ, Litzow, MR, Juckett, MB, Komanduri, KV, Lee, SJ, Devlin, SM, Costa, LJ, Khan, S, King, A, Klein, A, Krishnan, A, Malone, A, Mir, M, Moravec, C, Selby, G, Roy, V, Cochran, M, Stricherz, MK, Westmoreland, MD, Perales, MA & Wood, WA 2016, 'Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum', Biology of Blood and Marrow Transplantation, vol. 22, no. 3, pp. 564-570. https://doi.org/10.1016/j.bbmt.2015.12.008
Barba, P. ; Burns, L. J. ; Litzow, M. R. ; Juckett, M. B. ; Komanduri, Krishna V ; Lee, S. J. ; Devlin, S. M. ; Costa, L. J. ; Khan, S. ; King, A. ; Klein, A. ; Krishnan, A. ; Malone, A. ; Mir, M. ; Moravec, C. ; Selby, G. ; Roy, V. ; Cochran, M. ; Stricherz, M. K. ; Westmoreland, M. D. ; Perales, M. A. ; Wood, W. A. / Success of an International Learning Health Care System in Hematopoietic Cell Transplantation : The American Society of Blood and Marrow Transplantation Clinical Case Forum. In: Biology of Blood and Marrow Transplantation. 2016 ; Vol. 22, No. 3. pp. 564-570.
@article{fc879087a07e4490934d013aa5736cef,
title = "Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum",
abstract = "The American Society for Blood and Marrow Transplantation (ASBMT) Clinical Case Forum (CCF) was launched in 2014 as an online secure tool to enhance interaction and communication among hematopoietic cell transplantation (HCT) professionals worldwide through the discussion of challenging clinical care issues. After 14 months, we reviewed clinical and demographical data of cases posted in the CCF from January 29, 2014 to March 18, 2015. A total of 137 cases were posted during the study period. Ninety-two cases (67{\%}) were allogeneic HCT, 29 (21{\%}) were autologous HCT, and in 16 (12{\%}), the type of transplantation (autologous versus allogeneic) was still under consideration. The diseases most frequently discussed included non-Hodgkin lymphoma (NHL; n = 30, 22{\%}), acute myeloid leukemia (n = 23, 17{\%}), and multiple myeloma (MM; n = 20, 15{\%}). When compared with the US transplantation activity reported by the US Department of Health and Human Services, NHL and acute lymphoblastic leukemia cases were over-represented in the CCF, whereas MM was under-represented (P <.001). A total of 259 topics were addressed in the CCF with a median of 2 topics/case (range, 1 to 6). Particularly common topics included whether transplantation was indicated (n = 57, 41{\%}), conditioning regimen choice (n = 44, 32{\%}), and post-HCT complications after day 100 (n = 43, 31{\%}). The ASBMT CCF is a successful tool for collaborative discussion of complex cases in the HCT community worldwide and may allow identification of areas of controversy or unmet need from clinical, educational and research perspectives.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Autologous stem cell transplantation, Case discussions",
author = "P. Barba and Burns, {L. J.} and Litzow, {M. R.} and Juckett, {M. B.} and Komanduri, {Krishna V} and Lee, {S. J.} and Devlin, {S. M.} and Costa, {L. J.} and S. Khan and A. King and A. Klein and A. Krishnan and A. Malone and M. Mir and C. Moravec and G. Selby and V. Roy and M. Cochran and Stricherz, {M. K.} and Westmoreland, {M. D.} and Perales, {M. A.} and Wood, {W. A.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.bbmt.2015.12.008",
language = "English (US)",
volume = "22",
pages = "564--570",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Success of an International Learning Health Care System in Hematopoietic Cell Transplantation

T2 - The American Society of Blood and Marrow Transplantation Clinical Case Forum

AU - Barba, P.

AU - Burns, L. J.

AU - Litzow, M. R.

AU - Juckett, M. B.

AU - Komanduri, Krishna V

AU - Lee, S. J.

AU - Devlin, S. M.

AU - Costa, L. J.

AU - Khan, S.

AU - King, A.

AU - Klein, A.

AU - Krishnan, A.

AU - Malone, A.

AU - Mir, M.

AU - Moravec, C.

AU - Selby, G.

AU - Roy, V.

AU - Cochran, M.

AU - Stricherz, M. K.

AU - Westmoreland, M. D.

AU - Perales, M. A.

AU - Wood, W. A.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The American Society for Blood and Marrow Transplantation (ASBMT) Clinical Case Forum (CCF) was launched in 2014 as an online secure tool to enhance interaction and communication among hematopoietic cell transplantation (HCT) professionals worldwide through the discussion of challenging clinical care issues. After 14 months, we reviewed clinical and demographical data of cases posted in the CCF from January 29, 2014 to March 18, 2015. A total of 137 cases were posted during the study period. Ninety-two cases (67%) were allogeneic HCT, 29 (21%) were autologous HCT, and in 16 (12%), the type of transplantation (autologous versus allogeneic) was still under consideration. The diseases most frequently discussed included non-Hodgkin lymphoma (NHL; n = 30, 22%), acute myeloid leukemia (n = 23, 17%), and multiple myeloma (MM; n = 20, 15%). When compared with the US transplantation activity reported by the US Department of Health and Human Services, NHL and acute lymphoblastic leukemia cases were over-represented in the CCF, whereas MM was under-represented (P <.001). A total of 259 topics were addressed in the CCF with a median of 2 topics/case (range, 1 to 6). Particularly common topics included whether transplantation was indicated (n = 57, 41%), conditioning regimen choice (n = 44, 32%), and post-HCT complications after day 100 (n = 43, 31%). The ASBMT CCF is a successful tool for collaborative discussion of complex cases in the HCT community worldwide and may allow identification of areas of controversy or unmet need from clinical, educational and research perspectives.

AB - The American Society for Blood and Marrow Transplantation (ASBMT) Clinical Case Forum (CCF) was launched in 2014 as an online secure tool to enhance interaction and communication among hematopoietic cell transplantation (HCT) professionals worldwide through the discussion of challenging clinical care issues. After 14 months, we reviewed clinical and demographical data of cases posted in the CCF from January 29, 2014 to March 18, 2015. A total of 137 cases were posted during the study period. Ninety-two cases (67%) were allogeneic HCT, 29 (21%) were autologous HCT, and in 16 (12%), the type of transplantation (autologous versus allogeneic) was still under consideration. The diseases most frequently discussed included non-Hodgkin lymphoma (NHL; n = 30, 22%), acute myeloid leukemia (n = 23, 17%), and multiple myeloma (MM; n = 20, 15%). When compared with the US transplantation activity reported by the US Department of Health and Human Services, NHL and acute lymphoblastic leukemia cases were over-represented in the CCF, whereas MM was under-represented (P <.001). A total of 259 topics were addressed in the CCF with a median of 2 topics/case (range, 1 to 6). Particularly common topics included whether transplantation was indicated (n = 57, 41%), conditioning regimen choice (n = 44, 32%), and post-HCT complications after day 100 (n = 43, 31%). The ASBMT CCF is a successful tool for collaborative discussion of complex cases in the HCT community worldwide and may allow identification of areas of controversy or unmet need from clinical, educational and research perspectives.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Autologous stem cell transplantation

KW - Case discussions

UR - http://www.scopus.com/inward/record.url?scp=85009453056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009453056&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2015.12.008

DO - 10.1016/j.bbmt.2015.12.008

M3 - Article

C2 - 26718665

AN - SCOPUS:85009453056

VL - 22

SP - 564

EP - 570

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 3

ER -